BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 885 filers reported holding BAXTER INTL INC in Q3 2023. The put-call ratio across all filers is 0.40 and the average weighting 0.2%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,361,876 | -41.1% | 115,577 | -28.9% | 0.02% | -40.0% |
| Q2 2023 | $7,410,698 | -32.2% | 162,658 | -39.7% | 0.03% | -40.0% |
| Q1 2023 | $10,934,612 | -12.5% | 269,591 | +10.0% | 0.05% | -18.0% |
| Q4 2022 | $12,491,728 | -10.5% | 245,080 | -5.4% | 0.06% | -23.8% |
| Q3 2022 | $13,950,000 | -24.3% | 259,000 | -9.7% | 0.08% | -18.4% |
| Q2 2022 | $18,426,000 | +10.5% | 286,879 | +33.4% | 0.10% | +18.1% |
| Q1 2022 | $16,673,000 | +17.2% | 215,021 | +29.7% | 0.08% | +38.3% |
| Q4 2021 | $14,229,000 | +15.0% | 165,766 | +7.8% | 0.06% | +9.1% |
| Q3 2021 | $12,372,000 | -8.2% | 153,829 | -8.1% | 0.06% | -6.8% |
| Q2 2021 | $13,474,000 | -5.9% | 167,376 | -1.5% | 0.06% | -15.7% |
| Q1 2021 | $14,326,000 | +6.1% | 169,864 | +0.9% | 0.07% | 0.0% |
| Q4 2020 | $13,505,000 | +2.2% | 168,302 | +2.4% | 0.07% | -10.3% |
| Q3 2020 | $13,220,000 | -9.3% | 164,385 | -2.9% | 0.08% | -14.3% |
| Q2 2020 | $14,577,000 | +5.8% | 169,306 | -0.2% | 0.09% | -9.9% |
| Q1 2020 | $13,772,000 | -2.9% | 169,624 | +0.0% | 0.10% | +17.4% |
| Q4 2019 | $14,182,000 | -4.9% | 169,601 | -0.5% | 0.09% | -14.9% |
| Q3 2019 | $14,908,000 | +0.5% | 170,432 | -5.9% | 0.10% | -1.0% |
| Q2 2019 | $14,834,000 | -3.6% | 181,120 | -4.3% | 0.10% | -1.0% |
| Q1 2019 | $15,389,000 | +24.0% | 189,267 | +0.4% | 0.10% | +10.8% |
| Q4 2018 | $12,411,000 | -33.4% | 188,554 | -22.0% | 0.09% | -8.8% |
| Q3 2018 | $18,646,000 | +0.7% | 241,869 | -3.5% | 0.10% | -6.4% |
| Q2 2018 | $18,517,000 | +11.9% | 250,771 | -1.4% | 0.11% | +7.9% |
| Q1 2018 | $16,546,000 | -7.8% | 254,403 | -8.3% | 0.10% | -1.0% |
| Q4 2017 | $17,942,000 | -9.9% | 277,570 | -12.5% | 0.10% | -4.7% |
| Q3 2017 | $19,912,000 | +3.0% | 317,326 | -0.6% | 0.11% | -0.9% |
| Q2 2017 | $19,331,000 | +10.3% | 319,316 | -5.5% | 0.11% | +8.0% |
| Q1 2017 | $17,519,000 | +10.6% | 337,816 | -5.4% | 0.10% | +5.3% |
| Q4 2016 | $15,845,000 | -1.2% | 357,180 | +6.1% | 0.10% | -5.0% |
| Q3 2016 | $16,031,000 | +7.5% | 336,787 | +2.2% | 0.10% | -2.0% |
| Q2 2016 | $14,906,000 | +21.3% | 329,635 | +10.2% | 0.10% | +12.1% |
| Q1 2016 | $12,291,000 | +10.1% | 299,204 | +2.2% | 0.09% | +7.1% |
| Q4 2015 | $11,165,000 | +16.0% | 292,686 | -0.1% | 0.08% | +6.2% |
| Q3 2015 | $9,627,000 | -31.5% | 293,055 | -20.8% | 0.08% | -19.2% |
| Q2 2015 | $14,048,000 | -58.0% | 369,786 | -24.3% | 0.10% | -56.8% |
| Q1 2015 | $33,474,000 | -1.1% | 488,675 | +5.8% | 0.23% | -12.9% |
| Q4 2014 | $33,853,000 | +18.1% | 461,897 | +15.6% | 0.26% | +15.9% |
| Q3 2014 | $28,671,000 | -1.0% | 399,484 | -0.3% | 0.23% | +2.7% |
| Q2 2014 | $28,965,000 | -11.8% | 400,618 | -10.3% | 0.22% | -16.9% |
| Q1 2014 | $32,845,000 | +0.7% | 446,394 | -4.9% | 0.27% | -2.6% |
| Q4 2013 | $32,630,000 | +6.5% | 469,167 | +0.6% | 0.27% | +1.5% |
| Q3 2013 | $30,626,000 | +54.2% | 466,223 | +62.6% | 0.27% | +33.8% |
| Q2 2013 | $19,867,000 | – | 286,792 | – | 0.20% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SECTOR GAMMA AS | 713,500 | $49,895,000 | 12.74% |
| Veritas Asset Management LLP | 7,636,450 | $534,017,000 | 7.53% |
| FIRST NEW YORK SECURITIES LLC /NY | 154,158 | $10,780,269,000 | 5.40% |
| Gabalex Capital Management LLC | 200,000 | $14,981,000 | 5.39% |
| Veritas Investment Management LLP | 291,825 | $18,816,000 | 5.32% |
| Tweedy, Browne Co LLC | 2,543,966 | $177,900,000 | 4.91% |
| York Capital Management Global Advisors, LLC | 8,074,375 | $564,641,000 | 4.78% |
| First Fiduciary Investment Counsel, Inc. | 270,675 | $18,928,000 | 4.10% |
| SCHARF INVESTMENTS, LLC | 2,247,225 | $157,148,000 | 4.03% |
| Osher Van de Voorde Investment Management | 96,235 | $6,730,000 | 3.91% |